Breaking News Instant updates and real-time market news.

TODAY'S FREE FLY STORIES

Conference/Events
Celcuity to hold a conference call » 12:55
07/13/20
07/13
12:55
07/13/20
12:55
CELC

Celcuity

$5.73 /

-0.27 (-4.50%)

Conference call to review…

Conference call to review Celcuity's first test for ovarian cancer patients will be held on July 13 at 1 pm. Webcast Link

ShowHide Related Items >><<
CELC Celcuity
$5.73 /

-0.27 (-4.50%)

05/18/20 Craig-Hallum
Celcuity assumed with a Buy at Craig-Hallum
05/11/20 Craig-Hallum
Celcuity assumed with a Buy at Craig-Hallum
05/08/20 H.C. Wainwright
Celcuity price target lowered to $11 from $19 at H.C. Wainwright
Recommendations
Cineplex completing offering a positive, says CIBC » 12:53
07/13/20
07/13
12:53
07/13/20
12:53
CPXGF

Cineplex

$0.00 /

+ (+0.00%)

CIBC analyst Robert Bek…

CIBC analyst Robert Bek backed a Neutral rating and C$14 price target on Cineplex after the company completed a $275M convertible debenture deal. Bek said the completion of the offering is a positive, given it removes near-term liquidity risk.

ShowHide Related Items >><<
CPXGF Cineplex
$0.00 /

+ (+0.00%)

07/02/20 RBC Capital
Cineplex price target lowered to C$11 from C$13 at RBC Capital
07/02/20 BMO Capital
Cineplex price target lowered to C$12 from C$15 at BMO Capital
07/02/20 Scotiabank
Cineplex price target lowered to C$13 from C$15 at Scotiabank
07/02/20 TD Securities
Cineplex price target lowered to C$9.50 from C$15 at TD Securities
Recommendations
BMO backs Market Perform on Shaw Communications after Q3 results » 12:52
07/13/20
07/13
12:52
07/13/20
12:52
SJR

Shaw Communications

$17.63 /

+1.08 (+6.53%)

BMO Capital analyst Tim…

BMO Capital analyst Tim Casey backed a Market Perform rating and C$26 price target on Shaw Communications after the company's Q3 results beat expectations.

ShowHide Related Items >><<
SJR Shaw Communications
$17.63 /

+1.08 (+6.53%)

SJR Shaw Communications
$17.63 /

+1.08 (+6.53%)

07/13/20 TD Securities
Shaw Communications price target raised to C$32 from C$31 at TD Securities
07/13/20 Canaccord
Shaw Communications results beat as business remains solid, says Canaccord
06/03/20 Canaccord
Shaw Communications price target raised to C$26 from C$25 at Canaccord
06/02/20 National Bank
Shaw Communications price target raised to C$27 from C$26 at National Bank
SJR Shaw Communications
$17.63 /

+1.08 (+6.53%)

SJR Shaw Communications
$17.63 /

+1.08 (+6.53%)

Recommendations
Norbord valuation attractive at current levels, says BMO Capital » 12:50
07/13/20
07/13
12:50
07/13/20
12:50
OSB

Norbord

$26.49 /

-0.21 (-0.79%)

BMO Capital analyst Ketan…

BMO Capital analyst Ketan Mamtora reiterated an Outperform rating and C$32 price target on Norbord, saying near-term supply/demand fundamentals are "very healthy," and OSB pricing risk is skewed to the upside. Mamtora added that the valuation is attractive at current levels.

ShowHide Related Items >><<
OSB Norbord
$26.49 /

-0.21 (-0.79%)

OSB Norbord
$26.49 /

-0.21 (-0.79%)

07/09/20 Scotiabank
Norbord price target raised to C$36 from C$30 at Scotiabank
07/07/20 Credit Suisse
Norbord price target raised to C$30 from C$20
07/06/20 CIBC
Norbord price target raised to C$45 from C$37 at CIBC
06/15/20 CIBC
Norbord price target raised to C$37 from C$34 at CIBC
OSB Norbord
$26.49 /

-0.21 (-0.79%)

Recommendations
BMO backs Outperform on Alimentation Couche-Tard after store sale reports » 12:49
07/13/20
07/13
12:49
07/13/20
12:49
ANCUF

Alimentation Couche-Tard

$0.00 /

+ (+0.00%)

BMO Capital analyst Peter…

BMO Capital analyst Peter Sklar reiterated an Outperform rating and C$48 price target on BMO Capital following recent reports that the company has launched a process to sell 1,250 stores in the U.S. to facilitate the possible acquisition of Speedway.

ShowHide Related Items >><<
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

07/02/20 Scotiabank
Alimentation Couche-Tard price target raised to C$51 from C$44
07/02/20 TD Securities
Alimentation Couche-Tard price target raised to C$50 from C$49 at TD Securities
07/02/20 CIBC
Alimentation Couche-Tard price target raised to C$49 from C$46
07/01/20 BMO Capital
Alimentation Couche-Tard price target raised to C$48 from C$47 at BMO Capital
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

Options
SmileDirectClub call volume above normal and directionally bullish » 12:45
07/13/20
07/13
12:45
07/13/20
12:45
SDC

SmileDirectClub

$9.03 /

+0.79 (+9.59%)

Bullish option flow…

Bullish option flow detected in SmileDirectClub with 20,712 calls trading, 3x expected, and implied vol increasing over 14 points to 99.58%. Jul-20 9 calls and Jul-20 10 calls are the most active options, with total volume in those strikes near 9,400 contracts. The Put/Call Ratio is 0.13. Earnings are expected on August 12th.

ShowHide Related Items >><<
SDC SmileDirectClub
$9.03 /

+0.79 (+9.59%)

SDC SmileDirectClub
$9.03 /

+0.79 (+9.59%)

07/12/20 Stifel
Stifel likes near-term setup for SmileDirectClub, ups price target to $11
06/25/20
Fly Intel: Top five analyst initiations
06/25/20 Stephens
Stephens starts SmileDirectClub at Overweight with $11 price target
06/24/20 Stephens
SmileDirectClub initiated with an Overweight at Stephens
SDC SmileDirectClub
$9.03 /

+0.79 (+9.59%)

  • 12
    Sep
SDC SmileDirectClub
$9.03 /

+0.79 (+9.59%)

SDC SmileDirectClub
$9.03 /

+0.79 (+9.59%)

SDC SmileDirectClub
$9.03 /

+0.79 (+9.59%)

General news
Dallas Federal Reserve Bank President Robert Kaplan Speech to be released at 13:00  12:45
07/13/20
07/13
12:45
07/13/20
12:45
 
Conference/Events
National Press Club hosts a virtual event » 12:45
07/13/20
07/13
12:45
07/13/20
12:45

Federal Reserve Bank of…

Federal Reserve Bank of Dallas President Kaplan will deliver a live national address on why he believes continuous and widespread testing for COVID-19 is the key to restoring consumer confidence and jumpstarting America's economic recovery and will also discuss his outlook for the U.S. economy for the rest of 2020 and going into 2021 in a virtual event to be held on July 13 at 1 pm. Webcast Link

Recommendations
JPMorgan backs Neutral on Philips ahead of Q2 results » 12:42
07/13/20
07/13
12:42
07/13/20
12:42
PHG

Philips

$48.94 /

+1.74 (+3.69%)

JPMorgan analyst David…

JPMorgan analyst David Adlington reiterated a Neutral rating and EUR36.80 price target on Philips ahead of the company's Q2 results.

ShowHide Related Items >><<
PHG Philips
$48.94 /

+1.74 (+3.69%)

PHG Philips
$48.94 /

+1.74 (+3.69%)

07/09/20 Morgan Stanley
Philips price target raised to EUR 45 from EUR 44.11 at Morgan Stanley
06/22/20 Barclays
Philips price target raised to EUR 52 from EUR 50 at Barclays
04/22/20 Morgan Stanley
Philips price target lowered to EUR 45 from EUR 50 at Morgan Stanley
04/21/20 JPMorgan
Philips price target raised to EUR 36.80 from EUR 33.90 at JPMorgan
PHG Philips
$48.94 /

+1.74 (+3.69%)

Recommendations
JPMorgan backs Neutral on Intrum after Q2 pre-announcement » 12:41
07/13/20
07/13
12:41
07/13/20
12:41
ITJTY

Intrum

$0.00 /

+ (+0.00%)

JPMorgan analyst Gurjit…

JPMorgan analyst Gurjit Kambo reiterated a Neutral rating and SEK 140 price target on Intrum after the company pre-announced Q2 results.

ShowHide Related Items >><<
ITJTY Intrum
$0.00 /

+ (+0.00%)

07/13/20 UBS
Intrum Q2 pre-announcement better-than-expected, says UBS
05/13/20 UBS
Intrum price target lowered to SEK 135 from SEK 165 at UBS
03/31/20 JPMorgan
Intrum price target lowered to SEK 155 from SEK 295 at JPMorgan
On The Fly
Fly Insider: 89Bio, Aprea among week's notable insider trades » 12:40
07/13/20
07/13
12:40
07/13/20
12:40
ETNB

89bio

$33.16 /

+0.78 (+2.41%)

, VCNX

Vaccinex

$4.81 /

+0.86 (+21.77%)

, WTI

W&T Offshore

$2.36 /

+0.055 (+2.39%)

, COO

Cooper Companies

$288.19 /

-1.02 (-0.35%)

, SYNH

Syneos Health

$57.99 /

+1.58 (+2.80%)

, ADPT

Adaptive Biotechnologies

$47.00 /

+1.04 (+2.26%)

, ALNY

Alnylam

$161.08 /

-1.25 (-0.77%)

, BILL

Bill.com

$90.35 /

+0.66 (+0.74%)

, CIEN

Ciena

$54.81 /

-0.17 (-0.31%)

, APRE

Aprea Therapeutics

$29.35 /

-0.12 (-0.41%)

Welcome to "Fly Insider,"…

Open Full Text

ShowHide Related Items >><<
WTI W&T Offshore
$2.36 /

+0.055 (+2.39%)

VCNX Vaccinex
$4.81 /

+0.86 (+21.77%)

SYNH Syneos Health
$57.99 /

+1.58 (+2.80%)

ETNB 89bio
$33.16 /

+0.78 (+2.41%)

COO Cooper Companies
$288.19 /

-1.02 (-0.35%)

CIEN Ciena
$54.81 /

-0.17 (-0.31%)

BILL Bill.com
$90.35 /

+0.66 (+0.74%)

APRE Aprea Therapeutics
$29.35 /

-0.12 (-0.41%)

ALNY Alnylam
$161.08 /

-1.25 (-0.77%)

ADPT Adaptive Biotechnologies
$47.00 /

+1.04 (+2.26%)

ETNB 89bio
$33.16 /

+0.78 (+2.41%)

07/07/20 Chardan
89bio initiated with a Buy at Chardan
12/09/19 Oppenheimer
89bio initiated with an Outperform at Oppenheimer
12/09/19 SVB Leerink
89bio initiated with an Outperform at SVB Leerink
12/09/19 RBC Capital
89bio initiated with an Outperform at RBC Capital
VCNX Vaccinex
$4.81 /

+0.86 (+21.77%)

WTI W&T Offshore
$2.36 /

+0.055 (+2.39%)

04/17/20 Roth Capital
W&T Offshore upgraded to Buy from Neutral at Roth Capital
03/13/20 Roth Capital
W&T Offshore downgraded to Neutral from Buy at Roth Capital
03/09/20 Stifel
W&T Offshore downgraded to Hold from Buy at Stifel
COO Cooper Companies
$288.19 /

-1.02 (-0.35%)

07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/06/20 Baird
Cooper Companies downgraded to Neutral from Outperform at Baird
06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/26/20 Stephens
Cooper Companies price target raised to $325 from $300 at Stephens
SYNH Syneos Health
$57.99 /

+1.58 (+2.80%)

04/03/20 Mizuho
Syneos Health price target lowered to $42 from $56 at Mizuho
04/02/20 Credit Suisse
Syneos Health price target lowered to $62 from $72 at Credit Suisse
03/30/20 Goldman Sachs
Syneos Health downgraded to Neutral from Buy at Goldman Sachs
03/17/20 SunTrust
SunTrust cuts price targets across CROs, downgrades MedPace
ADPT Adaptive Biotechnologies
$47.00 /

+1.04 (+2.26%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
ALNY Alnylam
$161.08 /

-1.25 (-0.77%)

06/08/20 Cantor Fitzgerald
Alnylam lumasiran data reinforces confidence in efficacy, says Cantor Fitzgerald
06/07/20 Stifel
No surprises in 'positive' Alnylan Lumasiran ILLUMINATE-A data, says Stifel
05/12/20 RBC Capital
Alnylam initiated with a Sector Perform at RBC Capital
05/07/20 Oppenheimer
Alnylam price target raised to $162 from $140 at Oppenheimer
BILL Bill.com
$90.35 /

+0.66 (+0.74%)

06/29/20 Goldman Sachs
Bill.com price target raised to $90 from $60 at Goldman Sachs
05/28/20
Fly Intel: Top five analyst upgrades
05/28/20 Piper Sandler
Bill.com upgraded to Overweight from Neutral at Piper Sandler
05/18/20 KeyBanc
Bill.com price target raised to $85 from $76 at KeyBanc
CIEN Ciena
$54.81 /

-0.17 (-0.31%)

06/05/20 JPMorgan
JPMorgan ups Ciena target to $63 from $53, adds to Analyst Focus List
06/05/20 Stifel
Ciena price target raised to $61 from $54 at Stifel
06/05/20 Cowen
Ciena price target raised to $73 from $69 at Cowen
06/05/20 Barclays
Ciena price target raised to $67 from $48 at Barclays
APRE Aprea Therapeutics
$29.35 /

-0.12 (-0.41%)

06/22/20
Fly Intel: Top five analyst initiations
06/22/20 H.C. Wainwright
Aprea Therapeutics initiated with a Neutral at H.C. Wainwright
04/21/20
Fly Intel: Top five analyst initiations
04/20/20
Baird starts Aprea Therapeutics with Outperform on APR-246 potential
WTI W&T Offshore
$2.36 /

+0.055 (+2.39%)

VCNX Vaccinex
$4.81 /

+0.86 (+21.77%)

SYNH Syneos Health
$57.99 /

+1.58 (+2.80%)

ETNB 89bio
$33.16 /

+0.78 (+2.41%)

COO Cooper Companies
$288.19 /

-1.02 (-0.35%)

CIEN Ciena
$54.81 /

-0.17 (-0.31%)

BILL Bill.com
$90.35 /

+0.66 (+0.74%)

APRE Aprea Therapeutics
$29.35 /

-0.12 (-0.41%)

ALNY Alnylam
$161.08 /

-1.25 (-0.77%)

ADPT Adaptive Biotechnologies
$47.00 /

+1.04 (+2.26%)

  • 08
    Jul
  • 11
    Jun
  • 24
    Jan
  • 12
    Dec
  • 11
    Nov
  • 03
    Oct
SYNH Syneos Health
$57.99 /

+1.58 (+2.80%)

CIEN Ciena
$54.81 /

-0.17 (-0.31%)

WTI W&T Offshore
$2.36 /

+0.055 (+2.39%)

VCNX Vaccinex
$4.81 /

+0.86 (+21.77%)

ETNB 89bio
$33.16 /

+0.78 (+2.41%)

COO Cooper Companies
$288.19 /

-1.02 (-0.35%)

CIEN Ciena
$54.81 /

-0.17 (-0.31%)

BILL Bill.com
$90.35 /

+0.66 (+0.74%)

ADPT Adaptive Biotechnologies
$47.00 /

+1.04 (+2.26%)

WTI W&T Offshore
$2.36 /

+0.055 (+2.39%)

CIEN Ciena
$54.81 /

-0.17 (-0.31%)

BILL Bill.com
$90.35 /

+0.66 (+0.74%)

Recommendations
JPMorgan backs Underweight on Getinge ahead of Q2 results » 12:39
07/13/20
07/13
12:39
07/13/20
12:39
GNGBY

Getinge

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

JPMorgan analyst David Adlington reiterated an Underweight rating and SEK 158 price target on Getinge ahead of the company's Q2 results. Adlington said that updated consensus ahead of the results shows consensus estimates for Q2 have "moderated significantly" although he remains below on sales but slightly ahead on Adjusted EBITDA.

ShowHide Related Items >><<
GNGBY Getinge
$0.00 /

+ (+0.00%)

GNGBY Getinge
$0.00 /

+ (+0.00%)

06/17/20 Berenberg
Getinge price target raised to SEK 220 from SEK 210 at Berenberg
06/12/20 JPMorgan
Getinge price target raised to SEK 158 from SEK 153 at JPMorgan
04/23/20 JPMorgan
Getinge price target raised to SEK 153 from SEK 150 at JPMorgan
04/17/20 JPMorgan
Getinge price target raised to SEK 150 from SEK 120 at JPMorgan
Recommendations
JPMorgan cautious on 'unfavorable' earnings momentum for Essity » 12:34
07/13/20
07/13
12:34
07/13/20
12:34
ESSYY

Essity

$0.00 /

+ (+0.00%)

JPMorgan analyst Celine…

JPMorgan analyst Celine Pannuti reiterated an Underweight rating and SEK 290 price target on Essity, saying that she remains cautious on "unfavorable" earnings momentum ahead. The analyst noted there is downside risk to the Q2 EBITA consensus, and that overall she expects a weak Q2 to be weighed down by pantry de-loading in Retail and consumption declines in the out-of-home business.

ShowHide Related Items >><<
ESSYY Essity
$0.00 /

+ (+0.00%)

07/01/20 UBS
Essity price target lowered to SEK 316 from SEK 320
03/17/20 JPMorgan
Essity upgraded to Overweight from Neutral at JPMorgan
03/17/20 JPMorgan
Essity upgraded to Overweight from Neutral at JPMorgan
01/08/20 Goldman Sachs
Essity downgraded to Sell from Neutral at Goldman Sachs
Periodicals
Applied Therapeutics amendment 'bolsters' short seller accusations, STAT says » 12:33
07/13/20
07/13
12:33
07/13/20
12:33
APLT

Applied Therapeutics

$30.07 /

-0.51 (-1.67%)

Applied Therapeutics told…

Applied Therapeutics told a Wall Street analyst that it added new data and clarifying language about a clinical trial to an existing investor presentation on July 9 to "help investors better understand its work on an experimental drug for a rare metabolic disease," reported STAT's Adam Feuerstein. However, the company amended its investor presentation "in a way that bolsters accusations made by the author" of what the company called a "fraudulent short report" that it announced it was working with regulators and law enforcement to prosecute over, STAT's Feuerstein tells the pharma-focused site's subscribers in a report published behind a paywall. Reference Link

ShowHide Related Items >><<
APLT Applied Therapeutics
$30.07 /

-0.51 (-1.67%)

APLT Applied Therapeutics
$30.07 /

-0.51 (-1.67%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
APLT Applied Therapeutics
$30.07 /

-0.51 (-1.67%)

  • 24
    Jan
APLT Applied Therapeutics
$30.07 /

-0.51 (-1.67%)

APLT Applied Therapeutics
$30.07 /

-0.51 (-1.67%)

Recommendations
Ericsson 'very well positioned' into 5G cycle, says JPMorgan » 12:32
07/13/20
07/13
12:32
07/13/20
12:32
ERIC

Ericsson

$9.55 /

+0.125 (+1.33%)

JPMorgan analyst Sandeep…

JPMorgan analyst Sandeep Deshpande reiterated an Overweight rating and SEK 104 price target on Ericsson, saying the company is "very well positioned" into the 5G cycle with a "strong" product. The analyst noted that he sees Q2 results "marginally" below consensus, due to opex and not due to his view on the key gross profit.

ShowHide Related Items >><<
ERIC Ericsson
$9.55 /

+0.125 (+1.33%)

ERIC Ericsson
$9.55 /

+0.125 (+1.33%)

04/17/20 Credit Suisse
Ericsson price target raised to SEK 98 from SEK 97 at Credit Suisse
03/30/20 BofA
US 1 List changes at BofA
03/30/20 Cowen
Ericsson upgraded to Outperform from Market Perform at Cowen
03/27/20 Raymond James
Raymond James upgrades Ericsson with networking an essential service
ERIC Ericsson
$9.55 /

+0.125 (+1.33%)

ERIC Ericsson
$9.55 /

+0.125 (+1.33%)

ERIC Ericsson
$9.55 /

+0.125 (+1.33%)

ERIC Ericsson
$9.55 /

+0.125 (+1.33%)

Conference/Events
Wedbush specialty retail analyst to hold an analyst/industry conference call » 12:31
07/13/20
07/13
12:31
07/13/20
12:31
W

Wayfair

$223.81 /

+0.27 (+0.12%)

, BBBY

Bed Bath & Beyond

$7.84 /

-0.35 (-4.27%)

, HOME

At Home Group

$5.86 /

-0.09 (-1.51%)

, RH

RH

$270.20 /

+8.91 (+3.41%)

, WSM

Williams-Sonoma

$85.37 /

+0.2 (+0.23%)

Specialty Retail Analyst…

Specialty Retail Analyst Basham, along with Bryan Frank, Director at Kin + Carta Advisory and former Wayfair Head of Growth Strategy, assesses Wayfair's growth and profitability outlook on an Analyst/Industry conference call to b e held on July 13 at 1 pm.

ShowHide Related Items >><<
WSM Williams-Sonoma
$85.37 /

+0.2 (+0.23%)

W Wayfair
$223.81 /

+0.27 (+0.12%)

RH RH
$270.20 /

+8.91 (+3.41%)

HOME At Home Group
$5.86 /

-0.09 (-1.51%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

W Wayfair
$223.81 /

+0.27 (+0.12%)

07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
07/01/20 Deutsche Bank
Farfetch price target raised to $23 from $17 at Deutsche Bank
06/26/20 SunTrust
Wayfair price target raised to $208 from $163 at SunTrust
06/26/20 Wells Fargo
Wayfair price target raised to $215 from $170 at Wells Fargo
BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

07/10/20 Loop Capital
Bed Bath & Beyond price target raised to $9 from $5 at Loop Capital
07/07/20 Raymond James
Bed Bath & Beyond price target raised to $13 from $9 at Raymond James
05/26/20 Odeon Capital
Bed Bath & Beyond upgraded to Buy from Hold at Odeon Capital
04/16/20 Loop Capital
Bed Bath & Beyond Q4 results 'less bad than feared' says Loop Capital
HOME At Home Group
$5.86 /

-0.09 (-1.51%)

06/23/20 Loop Capital
Loop sees At Home, Dollar Tree as potential targets for activists
06/19/20 Loop Capital
At Home Group price target raised to $7 from $3 at Loop Capital
03/25/20 Guggenheim
Guggenheim cuts At Home Group to Neutral on 'unprecedented demand uncertainty'
03/25/20 Guggenheim
At Home Group downgraded to Neutral from Buy at Guggenheim
RH RH
$270.20 /

+8.91 (+3.41%)

06/16/20 Goldman Sachs
RH price target raised to $232 from $120 at Goldman Sachs
06/15/20 Loop Capital
RH upgraded to Buy from Hold at Loop Capital
06/15/20 Loop Capital
RH upgraded to Buy from Hold at Loop Capital
06/08/20 Loop Capital
RH price target raised to $250 from $110 at Loop Capital
WSM Williams-Sonoma
$85.37 /

+0.2 (+0.23%)

06/18/20
Fly Intel: Top five analyst initiations
06/18/20 Wells Fargo
Williams-Sonoma initiated with an Equal Weight at Wells Fargo
06/05/20 Argus
Williams-Sonoma price target raised to $95 from $80 at Argus
06/01/20 Loop Capital
Williams-Sonoma price target raised to $80 from $40 at Loop Capital
WSM Williams-Sonoma
$85.37 /

+0.2 (+0.23%)

W Wayfair
$223.81 /

+0.27 (+0.12%)

RH RH
$270.20 /

+8.91 (+3.41%)

HOME At Home Group
$5.86 /

-0.09 (-1.51%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

WSM Williams-Sonoma
$85.37 /

+0.2 (+0.23%)

W Wayfair
$223.81 /

+0.27 (+0.12%)

RH RH
$270.20 /

+8.91 (+3.41%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

WSM Williams-Sonoma
$85.37 /

+0.2 (+0.23%)

W Wayfair
$223.81 /

+0.27 (+0.12%)

RH RH
$270.20 /

+8.91 (+3.41%)

HOME At Home Group
$5.86 /

-0.09 (-1.51%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

WSM Williams-Sonoma
$85.37 /

+0.2 (+0.23%)

W Wayfair
$223.81 /

+0.27 (+0.12%)

RH RH
$270.20 /

+8.91 (+3.41%)

HOME At Home Group
$5.86 /

-0.09 (-1.51%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

Recommendations
Carlsberg H1 profit surprise should de-risk rest of 2020, says JPMorgan » 12:30
07/13/20
07/13
12:30
07/13/20
12:30
CABGY

Carlsberg

$0.00 /

+ (+0.00%)

JPMorgan analyst Fintan…

JPMorgan analyst Fintan Ryan backed an Overweight rating and DKK 1,050 price target on Carlsberg after the company pre-announced H1 results. Ryan said that the positive H1 profit surprise should de-risk the rest of 2020.

ShowHide Related Items >><<
CABGY Carlsberg
$0.00 /

+ (+0.00%)

CABGY Carlsberg
$0.00 /

+ (+0.00%)

07/13/20 Citi
Carlsberg 'surprised the market' with H1 pre-announcement, says Citi
07/13/20 Morgan Stanley
Carlsberg price target raised to DKK 1,000 from DKK 955 at Morgan Stanley
07/09/20 UBS
Carlsberg price target raised to DKK 720 from DKK 660 at UBS
07/02/20 Barclays
Carlsberg price target raised to DKK 988 from DKK 923 at Barclays
Recommendations
JPMorgan sees Aeroports de Paris H1 revenue falling EUR1B y/y » 12:28
07/13/20
07/13
12:28
07/13/20
12:28
AEOXF

Aeroports de Paris

$0.00 /

+ (+0.00%)

JPMorgan analyst Elodie…

JPMorgan analyst Elodie Rall reiterated an Underweight rating and EUR 90 price target on Aeroports de Paris ahead of the company's Q2 results on July 27. Rall said that, overall for H1, she expects revenues to fall by EUR1B year-over-year, EBITDA to fall EUR700M, and net income to fall EUR500M.

ShowHide Related Items >><<
AEOXF Aeroports de Paris
$0.00 /

+ (+0.00%)

06/25/20 Barclays
Aeroports de Paris price target lowered to EUR 72 from EUR 79 at Barclays
06/24/20 BofA
Aeroports de Paris downgraded to Underperform from Neutral at BofA
06/18/20 JPMorgan
Aeroports de Paris downgraded to Underweight from Neutral at JPMorgan
05/27/20 Goldman Sachs
Aeroports de Paris price target lowered to EUR 89 from EUR 99 at Goldman Sachs
Periodicals
Macau gets boost as neighboring province lifts quarantine rules, Bloomberg says » 12:26
07/13/20
07/13
12:26
07/13/20
12:26
LVS

Las Vegas Sands

$49.09 /

+3.37 (+7.37%)

, WYNN

Wynn Resorts

$81.98 /

+7.83 (+10.56%)

, MGM

MGM Resorts

$16.90 /

+0.71 (+4.39%)

, MLCO

Melco Resorts & Entertainment

$17.87 /

+2.27 (+14.55%)

Macau's neighboring…

Macau's neighboring Chinese province, Guangdong, announced on Monday that it will remove the 14-day quarantine requirement put in place in late March for travelers returning from the gaming area, reported Bloomberg's Jinshan Hong. The news, which is seen giving a boost to the world's largest gambling hub, has sent shares of Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO) higher. Reference Link

ShowHide Related Items >><<
MLCO Melco Resorts & Entertainment
$17.87 /

+2.27 (+14.55%)

MGM MGM Resorts
$16.90 /

+0.71 (+4.39%)

LVS Las Vegas Sands
$49.09 /

+3.37 (+7.37%)

LVS Las Vegas Sands
$49.09 /

+3.37 (+7.37%)

05/21/20
Fly Intel: Top five analyst upgrades
05/21/20 Credit Suisse
Credit Suisse upgrades Las Vegas Sands to Outperform with $58 target
05/21/20 Credit Suisse
Las Vegas Sands assumed with an Outperform from Neutral at Credit Suisse
05/06/20 Roth Capital
Las Vegas Sands price target lowered to $52 from $69 at Roth Capital
WYNN Wynn Resorts
$81.98 /

+7.83 (+10.56%)

06/11/20 JPMorgan
Wynn Resorts' Macau SAR results better than feared, says JPMorgan
05/27/20 Roth Capital
Wynn video 'clearly shows' Remark AI technology in use, says Roth Capital
05/21/20 Credit Suisse
Wynn Resorts assumed with a Neutral at Credit Suisse
05/07/20 Roth Capital
Wynn Resorts price target lowered to $99 from $104 at Roth Capital
MGM MGM Resorts
$16.90 /

+0.71 (+4.39%)

07/08/20 Jefferies
GVC has 'credible' U.S. sports betting aspirations, says Jefferies
06/12/20 SunTrust
SunTrust raises price target on select Gaming names amid positive room-rate data
06/10/20 Wolfe Research
MGM Resorts downgraded to Peer Perform from Outperform at Wolfe Research
05/21/20
Fly Intel: Top five analyst downgrades
MLCO Melco Resorts & Entertainment
$17.87 /

+2.27 (+14.55%)

05/15/20 Roth Capital
Melco Resorts & Entertainment the 'best Macau name,' says Roth Capital
04/20/20 Nomura Instinet
Melco price target lowered to $20 from $27 at Nomura Instinet
02/04/20 Bernstein
Bernstein sees Macau having 'solid' recovery in second half of 2020
01/28/20 JPMorgan
JPMorgan sees value in Gaming 'carnage,' Melco is top pick
WYNN Wynn Resorts
$81.98 /

+7.83 (+10.56%)

MLCO Melco Resorts & Entertainment
$17.87 /

+2.27 (+14.55%)

MGM MGM Resorts
$16.90 /

+0.71 (+4.39%)

LVS Las Vegas Sands
$49.09 /

+3.37 (+7.37%)

WYNN Wynn Resorts
$81.98 /

+7.83 (+10.56%)

MLCO Melco Resorts & Entertainment
$17.87 /

+2.27 (+14.55%)

MGM MGM Resorts
$16.90 /

+0.71 (+4.39%)

LVS Las Vegas Sands
$49.09 /

+3.37 (+7.37%)

WYNN Wynn Resorts
$81.98 /

+7.83 (+10.56%)

MLCO Melco Resorts & Entertainment
$17.87 /

+2.27 (+14.55%)

MGM MGM Resorts
$16.90 /

+0.71 (+4.39%)

LVS Las Vegas Sands
$49.09 /

+3.37 (+7.37%)

WYNN Wynn Resorts
$81.98 /

+7.83 (+10.56%)

MLCO Melco Resorts & Entertainment
$17.87 /

+2.27 (+14.55%)

MGM MGM Resorts
$16.90 /

+0.71 (+4.39%)

LVS Las Vegas Sands
$49.09 /

+3.37 (+7.37%)

Options
Chewy call volume above normal and directionally bullish » 12:25
07/13/20
07/13
12:25
07/13/20
12:25
CHWY

Chewy

$51.73 /

+3.16 (+6.51%)

Bullish option flow…

Bullish option flow detected in Chewy with 27,343 calls trading, 1.8x expected, and implied vol increasing over 6 points to 68.12%. Jul-20 50 calls and Jul-20 60 calls are the most active options, with total volume in those strikes near 8,600 contracts. The Put/Call Ratio is 0.11. Earnings are expected on September 8th.

ShowHide Related Items >><<
CHWY Chewy
$51.73 /

+3.16 (+6.51%)

CHWY Chewy
$51.73 /

+3.16 (+6.51%)

06/10/20 RBC Capital
Chewy price target raised to $62 from $40 at RBC Capital
06/10/20 JPMorgan
Chewy price target raised to $65 from $43 at JPMorgan
06/10/20 Credit Suisse
Chewy price target raised to $53 from $46 at Credit Suisse
06/10/20 Barclays
Chewy shares already reflect bullish outlook, says Barclays
CHWY Chewy
$51.73 /

+3.16 (+6.51%)

CHWY Chewy
$51.73 /

+3.16 (+6.51%)

CHWY Chewy
$51.73 /

+3.16 (+6.51%)

CHWY Chewy
$51.73 /

+3.16 (+6.51%)

Conference/Events
Wedbush retail/hardlines analyst to hold an analyst/industry conference call » 12:25
07/13/20
07/13
12:25
07/13/20
12:25
W

Wayfair

$223.00 /

-0.54 (-0.24%)

, BBBY

Bed Bath & Beyond

$7.84 /

-0.35 (-4.27%)

, HOME

At Home Group

$5.90 /

-0.055 (-0.92%)

, RH

RH

$273.02 /

+11.73 (+4.49%)

, WSM

Williams-Sonoma

$85.66 /

+0.49 (+0.58%)

Retail/Hardlines Analyst…

Retail/Hardlines Analyst Basham, along with Bryan Frank, Director at Kin + Carta, assess Wayfair's growth and profitability outlook on an Analyst/Industry conference call to be held on July 13 at 1 pm.

ShowHide Related Items >><<
WSM Williams-Sonoma
$85.66 /

+0.49 (+0.58%)

W Wayfair
$223.00 /

-0.54 (-0.24%)

RH RH
$273.02 /

+11.73 (+4.49%)

HOME At Home Group
$5.90 /

-0.055 (-0.92%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

W Wayfair
$223.00 /

-0.54 (-0.24%)

07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
07/01/20 Deutsche Bank
Farfetch price target raised to $23 from $17 at Deutsche Bank
06/26/20 SunTrust
Wayfair price target raised to $208 from $163 at SunTrust
06/26/20 Wells Fargo
Wayfair price target raised to $215 from $170 at Wells Fargo
BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

07/10/20 Loop Capital
Bed Bath & Beyond price target raised to $9 from $5 at Loop Capital
07/07/20 Raymond James
Bed Bath & Beyond price target raised to $13 from $9 at Raymond James
05/26/20 Odeon Capital
Bed Bath & Beyond upgraded to Buy from Hold at Odeon Capital
04/16/20 Loop Capital
Bed Bath & Beyond Q4 results 'less bad than feared' says Loop Capital
HOME At Home Group
$5.90 /

-0.055 (-0.92%)

06/23/20 Loop Capital
Loop sees At Home, Dollar Tree as potential targets for activists
06/19/20 Loop Capital
At Home Group price target raised to $7 from $3 at Loop Capital
03/25/20 Guggenheim
Guggenheim cuts At Home Group to Neutral on 'unprecedented demand uncertainty'
03/25/20 Guggenheim
At Home Group downgraded to Neutral from Buy at Guggenheim
RH RH
$273.02 /

+11.73 (+4.49%)

06/16/20 Goldman Sachs
RH price target raised to $232 from $120 at Goldman Sachs
06/15/20 Loop Capital
RH upgraded to Buy from Hold at Loop Capital
06/15/20 Loop Capital
RH upgraded to Buy from Hold at Loop Capital
06/08/20 Loop Capital
RH price target raised to $250 from $110 at Loop Capital
WSM Williams-Sonoma
$85.66 /

+0.49 (+0.58%)

06/18/20
Fly Intel: Top five analyst initiations
06/18/20 Wells Fargo
Williams-Sonoma initiated with an Equal Weight at Wells Fargo
06/05/20 Argus
Williams-Sonoma price target raised to $95 from $80 at Argus
06/01/20 Loop Capital
Williams-Sonoma price target raised to $80 from $40 at Loop Capital
WSM Williams-Sonoma
$85.66 /

+0.49 (+0.58%)

W Wayfair
$223.00 /

-0.54 (-0.24%)

RH RH
$273.02 /

+11.73 (+4.49%)

HOME At Home Group
$5.90 /

-0.055 (-0.92%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

WSM Williams-Sonoma
$85.66 /

+0.49 (+0.58%)

W Wayfair
$223.00 /

-0.54 (-0.24%)

RH RH
$273.02 /

+11.73 (+4.49%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

WSM Williams-Sonoma
$85.66 /

+0.49 (+0.58%)

W Wayfair
$223.00 /

-0.54 (-0.24%)

RH RH
$273.02 /

+11.73 (+4.49%)

HOME At Home Group
$5.90 /

-0.055 (-0.92%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

WSM Williams-Sonoma
$85.66 /

+0.49 (+0.58%)

W Wayfair
$223.00 /

-0.54 (-0.24%)

RH RH
$273.02 /

+11.73 (+4.49%)

HOME At Home Group
$5.90 /

-0.055 (-0.92%)

BBBY Bed Bath & Beyond
$7.84 /

-0.35 (-4.27%)

Conference/Events
UBS consumer services/products analysts hold an analyst/industry conference call » 12:25
07/13/20
07/13
12:25
07/13/20
12:25

Consumer Services &…

Consumer Services & Products Analysts Lasser & Maheshwari provides an update on the Home Furnishings & Mattress Industries on an Analyst/Industry conference call to be held on July 13 at 1 pm.

Conference/Events
Wolfe Research multi-industry analyst to hold analyst/industry webcast » 12:25
07/13/20
07/13
12:25
07/13/20
12:25

Multi-Industry Analysts…

Multi-Industry Analysts provide a preview of 2Q20 earnings on an Analyst/Industry webcast to be held on July 13 at 1 pm.

Conference/Events
Nutanix participates in a conference call with JMP Securities » 12:25
07/13/20
07/13
12:25
07/13/20
12:25
NTNX

Nutanix

$22.95 /

-0.37 (-1.59%)

Cybersecurity & IT…

Cybersecurity & IT Infrastructure Analyst Suppiger holds a conference call with CFO Williams on July 13 at 1 pm hosted by JMP Securities.

ShowHide Related Items >><<
NTNX Nutanix
$22.95 /

-0.37 (-1.59%)

NTNX Nutanix
$22.95 /

-0.37 (-1.59%)

05/28/20 RBC Capital
Nutanix price target raised to $27 from $23 at RBC Capital
05/28/20 Wells Fargo
Nutanix price target raised to $27 from $22 at Wells Fargo
05/28/20 JMP Securities
Nutanix price target lowered to $45 from $52 at JMP Securities
05/21/20 JPMorgan
Nutanix price target lowered to $24 from $27 at JPMorgan
NTNX Nutanix
$22.95 /

-0.37 (-1.59%)

NTNX Nutanix
$22.95 /

-0.37 (-1.59%)

NTNX Nutanix
$22.95 /

-0.37 (-1.59%)

NTNX Nutanix
$22.95 /

-0.37 (-1.59%)

Conference/Events
Susquehanna social media analysts to hold an analyst/industry conference call » 12:25
07/13/20
07/13
12:25
07/13/20
12:25

Social Media Analysts,…

Social Media Analysts, along with a leading U.S. independent social ad agency, discuss social ad trends on an Analyst/Industry conference call to be held on July 13 at 1 pm.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.